Ozempic vs Wegovy: Key Differences Explained

Educational only, not medical advice; consult a licensed clinician.

If you have heard Ozempic and Wegovy talked about as if they were two different drugs, you are not alone. They are both brand-name injectable medications, and they both contain the same active ingredient, semaglutide, a GLP-1 receptor agonist. They share that molecule, but the FDA approves them for different uses and they are dosed differently. Here is a grounded look at how they compare, written for patients in the Louisville and Kentucky area.

Same Drug, Different Approvals

The main thing to know is that Ozempic and Wegovy are both semaglutide, and both are made by Novo Nordisk. What sets them apart is their FDA-approved uses and labeled dosing, not the medicine itself.

• Ozempic is approved to improve blood sugar (glycemic) control in adults with type 2 diabetes, and to lower the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
• Wegovy is approved for chronic weight management in adults and certain adolescents who meet specific body mass index (BMI) criteria. It is used along with a reduced-calorie diet and more physical activity.

How They Work

As GLP-1 receptor agonists, both medications copy a hormone your body makes naturally. That hormone helps manage appetite, slows how fast your stomach empties, and supports insulin release in response to food. This shared action is why both can affect appetite and weight, even though only Wegovy is labeled specifically for weight management.

Dosing Differences

Both are given as a once-weekly injection under the skin, but their maximum labeled doses are not the same. The dose is raised slowly to ease gastrointestinal side effects. Wegovy is labeled to reach a higher maintenance dose than Ozempic. The exact dose levels and titration schedule are set by a clinician, based on the product label and how you respond.

Side Effects

Because they share an active ingredient, Ozempic and Wegovy have overlapping side effects. Commonly reported effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. These often ease over time as the dose is raised. Both carry a boxed warning about the risk of thyroid C-cell tumors seen in rodent studies. They are not recommended for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Talk to a clinician about any symptoms that concern you.

Frequently Asked Questions

Are Ozempic and Wegovy the same medication?

They contain the same active ingredient, semaglutide, and they are made by the same manufacturer. They differ in their FDA-approved uses and labeled dosing. Ozempic is approved for type 2 diabetes and cardiovascular risk reduction, while Wegovy is approved for chronic weight management.

Can Ozempic be used for weight loss?

Ozempic is FDA-approved for type 2 diabetes, not for weight loss. Weight change can happen with GLP-1 receptor agonists, but using a medication outside its labeled use is a clinical decision you should make with a licensed clinician.

Which one causes more side effects?

Because both contain semaglutide, their side effects overlap. Gastrointestinal effects such as nausea are common with both and tend to improve as the dose is raised gradually. How well each person tolerates them varies.

How are they administered?

Both are once-weekly injections given under the skin (subcutaneous). They are usually self-administered with a prefilled pen, after you receive proper instruction from a clinician or pharmacist.

How do I know which option is appropriate for me?

The right choice depends on your medical history, your current conditions, and your treatment goals. A licensed clinician can review your health profile and talk through your options with you. You can start by completing our health assessment.

Educational only, not medical advice; consult a licensed clinician.